Xiangxue Pharmaceutical's low P/S ratio may be due to declin...
Xiangxue Pharmaceutical's low P/S ratio may be due to declining revenue and expectations of this trend continuing, potentially disappointing shareholders. Significant share price movement seems unlikely given current circumstances and recent revenue trends.
Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) 29% Dip In Price Shows Sentiment Is Matching Revenues
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment